Nordea Investment Management
PACB icon

Nordea Investment Management’s Pacific Biosciences PACB Stock Holding History

Nordea Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-884,642
Closed -$1.01M – 886
2025
Q1 		$1.01M Buy
884,642
+367,457
+71% +$564K ﹤0.01% 809
2024
Q4 		$915K Buy
517,185
+91,559
+22% +$179K ﹤0.01% 818
2024
Q3 		$747K Sell
425,626
-6,711
-2% -$11K ﹤0.01% 848
2024
Q2 		$594K Buy
432,337
+218,182
+102% +$441K ﹤0.01% 866
2024
Q1 		$815K Buy
214,155
+71,398
+50% +$418K ﹤0.01% 851
2023
Q4 		$1.41M Sell
142,757
-6,374
-4% -$52.1K ﹤0.01% 762
2023
Q3 		$1.25M Buy
149,131
+40,667
+37% +$465K ﹤0.01% 771
2023
Q2 		$1.5M Sell
108,464
-26,952
-20% -$328K ﹤0.01% 739
2023
Q1 		$1.45M Buy
+135,416
New +$1.35M ﹤0.01% 719

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nordea Investment Management's PACB Position: Q2 2025 in Review

Nordea Investment Management sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 884,642 shares — an estimated $1.01M sold.

Nordea Investment Management first reported a position in PACB in Q1 2023 and held it in 9 quarters. The position peaked at $1.5M in Q2 2023. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Nordea Investment Management reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Nordea Investment Management sold 884,642 Pacific Biosciences shares in Q2 2025, an estimated $1.01M.
  • Nordea Investment Management first reported a position in Pacific Biosciences in Q1 2023 and held it in 9 quarters.
  • Nordea Investment Management's Pacific Biosciences position peaked at $1.5M in Q2 2023.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Nordea Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.